Engineered proteins that help carry oxygen to cancer tumors may improve the odds of successful treatment for approximately half of all cancer patients. Scientists have long known that low levels of oxygen are a main source of a tumor’s resistance to radiation. It is estimated that 50 percent of all cancer patients have tumors that

Child cancer patients who have been treated with the chemotherapy drug anthracycline are three times more likely to suffer from cardiac death 30 years after treatment than children not treated with the drug. Now, a complementary drug given during the time of chemotherapy has been shown to significantly improve long-term heart health, according to researchers

Thanks to advancement made possible through the Human Genome Project, British researchers believe the world’s first cancer-killing pill may be on the horizon. According to the team’s timeline, such a pill may be available in as few as ten years. The success of this future pill will work by exploiting a specific gene flaw that

A number of studies have shown that combination chemotherapy (using two or more cancer drugs simultaneously) can help improve treatment of some cancer types. Regulation of combination dosages has been difficult, however, due to the lack of accuracy associated with drug dissemination. Specifically, past studies have shown that combination therapies have difficulty targeting cancer cells

A few years ago, gefitinib was written off as an ineffective drug treatment for lung cancer. This conclusion was based on a 2004 study that found no correlation between gefitinib and prolonged lifespan among lung cancer participants. However, scientists who revisited the drug eventually found that gefitinib is exceptionally effective in treating a small minority